E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma
1996

E-cadherin and Breast Cancer

Sample size: 187 publication Evidence: moderate

Author Information

Author(s): JL Jones, JE Royall, RA Walker

Primary Institution: University of Leicester

Hypothesis

The study aims to examine the expression of E-cadherin in primary breast carcinomas and its relationship with clinicopathological parameters.

Conclusion

The study found a significant association between reduced E-cadherin expression and the presence of lymph node metastasis in breast cancer.

Supporting Evidence

  • 93% of infiltrating ductal carcinomas showed some evidence of E-cadherin staining.
  • Reduced membrane reactivity of E-cadherin was significantly associated with lymph node metastasis.
  • A highly significant correlation was found between cytoplasmic E-cadherin reactivity and lymph node metastasis.

Takeaway

E-cadherin is a protein that helps cells stick together, and in breast cancer, lower levels of it can mean the cancer has spread to lymph nodes.

Methodology

The study used immunohistochemical techniques to examine E-cadherin expression in breast cancer tissue samples and correlated findings with clinicopathological data.

Limitations

The study's findings may not apply to all breast cancer types due to the small sample sizes of certain carcinoma types.

Participant Demographics

The study included 187 patients with various types of breast carcinoma, including infiltrating ductal and lobular carcinomas.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication